APA (7th ed.) Citation

J, L., C, O., K, H., J, G., V, K., B, D., . . . HM, M. (2026). Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-71233-1

Chicago Style (17th ed.) Citation

J, Liang, et al. "Loss of Luminal Lineage Drives Resistance to Next-generation ERα Antagonists in Pretreated ER+ HER2- Locally-advanced or Metastatic Breast Cancer." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-71233-1.

MLA (9th ed.) Citation

J, Liang, et al. "Loss of Luminal Lineage Drives Resistance to Next-generation ERα Antagonists in Pretreated ER+ HER2- Locally-advanced or Metastatic Breast Cancer." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-71233-1.